Title: Glycaemic Control and Complications

Authors: P. Rajeshwari, P.R. Prasad, M. Nagaprasanth, Salma Mahaboob R

 DOI: https://dx.doi.org/10.18535/jmscr/v6i11.131

Abstract

Introduction

Diabetes mellitus complications a group of metabolic disorders presenting with hyperglycemia resulting from insulin deficiency or decreased glucose utilization and increased glucose production. The metabolic abnormalities of diabetes mellitus causes secondary pathophysiological changes in multiple organ system resulting in increased morbidity and mortality.

References

  1. Williams textbook of endocrinology (12th ed.). Philadelphia: Elsevier/Saunders. pp. 1371–1435. ISBN 978-1-4377-0324-5.
  2. Simple treatment to curb diabetes. , January 20, 2014.
  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 2004; 27 (5): 1047–53.
  4. Bengtsson C, Lapidus L, Stendahal C, Waldenstrom J. 2002. “Hyper uricemia and risk of cardiovascular disease and overall death”. Acta Med Scand; 224: 549-555.
  5. M Deepa, S Farooq, M Datta, R Deepa, V Mohan: “Prevalence of metabolic syndrome using WHO, ATP-III and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES- 34)”. Diabetes/Metabolism Research and Reviews. 2006; 23 (2): 127-134.
  6. Diagnosis and classification of diabetes mellitus”. American diabetes association. Diabetic care. 2012; 35.(1): 64-71.
  7. Clinical Medicine Dr. praveen kumar and michale clark, 6th edition, 2005.
  8. Definition, Diagnosis and Classification of diabetes mellitus and its complications. World health organization”. W.H.O Consultation. Dept. of Non communicable disease surveillance. WHO/NCD/ NCS/99.(2).1999;(1)-49.
  9. Klein BE, Klein R, Lee KE: “Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care 2002”; 25: 1790 – 1794.
  10. Role of insulin resistance in human disease”. Reaven GM: Banting lecture 1988.Diabetes 1988; 37: 1595 – 1607.
  11. Malik S, Wong ND, Franklin SS, et al: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245 – 1250.
  12. Neumann NU, Frasch K: “Coherences between the metabolic syndrome, depression, stress and physical activity”. Psychiatr Prax 2008; 36: 110 – 114 [in German].
  13. Hall MH, Muldoon MF, Jennings JR, et al: Self- reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep 2008; 31: 635 – 643.
  14. Pryor, WA. (ed.), Free Radicals in Biology, vols. 1-5, Academic Press, New York, 1981.
  15. Ames, BN., Cathcart, R., Schwiers, E. & Hochstein, P. (1981) Proc. Natl. Acad. Sci. U.S.A. 78, 6858- 6862
  16. Simon, MI. & Van Vunakis, H., Arch. Biochem. Biophys. 1964; 105, 197-206
  17. Howell, RR. & Wyngaarden, JB, J. Biol. Chem., 1960; 235: 3544-3550
  18. Matsushita, S., Ibuki, F. & Aoki, A., Arch. Biochem. Biophys. 1963; 102: 446-451
  19. Kellogg, EW., III & Fridovich, I., J. Biol. Chem. 1971; 252: 6721-6728
  20. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114: 1752–1761.

Corresponding Author

M Nagaprasanth

Assistant Professor in Urology at Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.